Evidence map›Paper›PMID 33982814›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2021

Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.

B M Cyrenne, F Al-Mohammedi, J G DeKoven, R Alhusayen

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Pityriasis Rosea Induced by COVID-19 Vaccination.European journal of case reports in internal medicine · 2022
    Article
  20. Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccine.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

B M CyrenneDivision of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.ORCID 0000-0001-7220-4983
F Al-MohammediDivision of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
J G DeKovenDivision of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
R AlhusayenDivision of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Pityriasis RoseaBNT162 VaccineCOVID-19 VaccinesHumansRNA, MessengerSARS-CoV-2VaccinationBNT162 VaccineCOVID-19 VaccinesRNA, Messenger

Identifiers

PMID33982814
PMCPMC8242636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.